RxDoctor Payments Data

Michelle Doran

Gerontology · Salem, MANPI 1992751416

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $526,680 of the $697,828 with a category attached, or 75.5%. AbbVie accounts for 99.8% of it on its own, with 5 other manufacturers making up the rest. Among gerontology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$697,828in general payments, 2019–2025

Across 902 payments — averaging $773.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$697K
  • Revance Therapeutics, Inc.$778
  • Galderma Laboratories, L.p.$325
  • Merz North America, Inc.$88
  • Lilly USA, LLC$16
  • Acelrx Pharmaceuticals, Inc.$13

What the payments were for

  • Consulting fees$64,0219%
  • Speaking & faculty fees$526,68075%
  • Travel & lodging$87,36913%
  • Food & beverage$19,7583%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$697,828 in reported general payments places this provider in the 95th percentile of 168 gerontology providers in Massachusetts.

See all gerontology providers in Massachusetts

Other gerontology in Salem

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →